Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04156854 · ClinicalTrials.gov registry record · NA
Intravascular Volume Expansion to Neuroendocrine-Renal Function Profiles in Chronic Heart Failure
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT04156854: Completed NA study, sponsored by Mayo Clinic.
NCT04156854 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 15 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04156854, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
Researchers are trying learn more about how the heart and blood volume interact in subjects with heart failure and how measuring blood volume may help them develop better ways of treating and managing heart failure patients.
Primary Outcome
Measured in milliliters
Interventions
- DIAGNOSTIC_TEST Quantitated Blood Volume Analysis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2020-01-30 |
| Est. Completion | 2022-12-19 |
| Phase | NA |
What the finished NCT04156854 record still lists
NCT04156854 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Quantitated Blood Volume Analysis is the first listed.
NCT04156854 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04156854 about?
NCT04156854 is a clinical study titled "Intravascular Volume Expansion to Neuroendocrine-Renal Function Profiles in Chronic Heart Failure". Researchers are trying learn more about how the heart and blood volume interact in subjects with heart failure and how measuring blood volume may help them develop better ways of treating and managing heart failure patients.
What is the current status of trial NCT04156854?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2020-01-30. Estimated completion is 2022-12-19.
What interventions are being tested in trial NCT04156854?
The interventions under investigation include: Quantitated Blood Volume Analysis (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04156854?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04156854's enrollment target sits among peer trials
15 1881st of 2000 higher than 92 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI